Alnylam Outlines 2016 Goals for RNAi Therapeutics Pipeline
Go back to Alnylam Outlines 2016 Goals for RNAi Therapeutics Pipeline| Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) | Delayed: 224.60 -4.05 (1.77%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $228.65 | 52 Week High | $109.10 | |||
| Open | $225.76 | 52 Week Low | $31.38 | |||
| Day High | $227.99 | P/E | N/A | |||
| Day Low | $222.12 | EPS | $-1.45 | |||
| Volume | 1,375,803 | |||||
| Kirin Holdings Company, Limited Sponsored ADR (AMEX: KNBWY) | Delayed: 18.90 -0.69 (3.52%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $19.59 | 52 Week High | $18.64 | |||
| Open | $18.88 | 52 Week Low | $12.59 | |||
| Day High | $18.95 | P/E | N/A | |||
| Day Low | $18.78 | EPS | $0.00 | |||
| Volume | 14,399 | |||||
